1998
DOI: 10.2337/diacare.21.6.930
|View full text |Cite
|
Sign up to set email alerts
|

Well-Being and Treatment Satisfaction in Older People With Diabetes

Abstract: It has proved possible to measure well-being and treatment satisfaction in a large community-based samples of older people with diabetes. At the level of glycemic control in this population, neither parameter correlated with HbA1c. The lower well-being in insulin-treated patients remained significant in multivariate analysis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

10
58
4
1

Year Published

1999
1999
2013
2013

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 109 publications
(77 citation statements)
references
References 13 publications
(27 reference statements)
10
58
4
1
Order By: Relevance
“…Our results are consistent with other studies that have demonstrated lower health-utility scores in women with diabetes [6,[31][32][33] and worse QoL in the presence of complications [6,20,33,34]. However, even with inclusion of gender and diabetic complications in the model, frequency of hyperglycemic symptoms was associated with lower health-utility scores.…”
Section: Discussionsupporting
confidence: 92%
“…Our results are consistent with other studies that have demonstrated lower health-utility scores in women with diabetes [6,[31][32][33] and worse QoL in the presence of complications [6,20,33,34]. However, even with inclusion of gender and diabetic complications in the model, frequency of hyperglycemic symptoms was associated with lower health-utility scores.…”
Section: Discussionsupporting
confidence: 92%
“…In diabetic populations, 2.0 to about 2.5 points is a reasonable estimate of the smallest clinically important difference in either physical or mental component summary scores [17]. The validity of the SF-36 has been demonstrated in several studies of diabetic participants [14,[18][19][20][21][22].…”
Section: Methodsmentioning
confidence: 99%
“…However, others have found lower treatment satisfaction in patients taking insulin. 30 Although the advantages of better metabolic control in patients with type 2 diabetes have been advocated for a long time, in particular for patients aged 40-55 years, 31,32 this has recently been challenged by a study showing that intensive glucose therapy may be beneficial only in patients aged 65 or fewer years. 33 The clinical decision to initiate insulin requires that the benefits should outweigh the risks.…”
Section: Limitationsmentioning
confidence: 99%